Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
Germany
Department of Neurology, University of Ulm, Ulm, Baden-Wurttemberg Age range
18 Years and older
Last updated December 2024